2020 · Q56
Which one of the following Indian institutes was approved by the Drugs Controller General of India for conducting human trials of the Oxford-AstraZeneca Covid-19 vaccine candidate?
General KnowledgeCurrent Affairs
- ABharat Biotech
- BAIIMS
- CSerum Institute of India
- DNational Institute of Epidemiology
Explanation
The Serum Institute of India, Pune — the world's largest vaccine manufacturer — was approved by the DCGI to conduct human trials in India of the Oxford-AstraZeneca vaccine candidate (Covishield). Bharat Biotech was developing its own Covaxin, while AIIMS and NIE were trial sites rather than the approved sponsor. The correct answer is the Serum Institute of India.